ArticleKidney research and clinical practice2026
Outpatient visit intervals in chronic kidney disease: adherence to Kidney Disease: Improving Global Outcomes recommendations and determinants of variation.
Article in Kidney research and clinical practice, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
backgroundChronic kidney disease (CKD) is a major global health problem owing to its progressive nature, complications, and substantial healthcare burden. The Kidney Disease: Improving Global Outcomes (KDIGO) guidelines recommend outpatient visit intervals based on CKD severity; however, adherence to these recommendations and the factors influencing the visit interval remain unclear.
methodsThis retrospective observational study included 13,621 patients with CKD treated at a tertiary hospital in South Korea. Using electronic medical records, we used linear regression and Shapley Additive exPlanations (SHAP), a method for interpreting model prediction, to assess the influence of clinical, demographic, and healthcare utilization factors on outpatient visit intervals. Key variables included the CKD stage, comorbidities, age, distance to the hospital, and physician assignment.
resultsVisit intervals shortened as CKD severity increased, although variability was substantial. Adherence to KDIGO-recommended intervals was higher in earlier CKD stages, but declined in intermediate and advanced stages, except for stage G5-A3, where 90.0% of visits met guidelines. Shorter intervals were associated with advanced stage, older age, greater healthcare use, and shorter distance to the hospital. SHAP analysis confirmed these predictors, identifying CKD stage as the dominant factor and revealing notable physician-level variation.
conclusionCKD stage was the primary determinant of outpatient follow-up intervals, but adherence to KDIGO recommendations varied across stages. Visit schedules were also affected by age, comorbidities, healthcare utilization, accessibility, and physician practice. These findings underscore the need for tailored follow-up strategies that reflect both disease severity and clinical context.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.